Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Leo needs to update the situation. The longer this drags on the chances are he's hiding something. The results should be known by now... Also, what's the status with B and K?
Clinical trials last update on May 2, 2016... Study completion date still May... Just a matter of days or hours for an update. Will be interesting to see if a partner is announced with positive results? My guess is that negotiations have been ongoing.
https://clinicaltrials.gov/ct2/show?term=prurisol&rank=2
The rally from 1.45 to 1.80 is more than little investors... Previous rallies were always sold after a few days. This has sustaining power... Insiders meaning, those in the know... Inside info can be shared many ways...
1.80 holds again with no news, while the market has been in decline mode.... Tells me insiders are scooping up shares on dips... Meaning, great news in on-the-way.
Be sure to let us know when you exit. It was too much pain holding these shares... About 100 posts since you arrived here, while the stock continues to climb... Keep up the good work.
1.80 held once again, look for a rally tomorrow above 1.90 with a crack at 2... The doubters posted a few times today only to be reminded that things have changed... Momentum is clearly higher at this point... Either join the party or move on to another short position...
Great close!!! Dud is wrong as usual!! CTIX Outperformed the market once again...
Please disregard the daily short totals (FINRA) that are posted here on a daily basis. It's a bogus report... See below...
The daily short interest report from FINRA is as widely misinterpreted as any report ever put out. Yet, once a few basics are understood, it becomes very logical. The huge short volume seen in the daily reports are almost instantaneously covered; within a few milliseconds or a few hours at worst. The best explanation of this report, that I've ever seen, was posted by "Dave Patch" of "Investigatethesec.com."
Posted by: patchman Date: Wednesday, March 03, 2010 6:31:31 PM
In reply to: fourkids_9pets who wrote msg# 648 Post # of 951
Short Sale Volume Reporting’s are deceiving.
I spoke to FINRA today and found out some very interesting things that until now I did not fully understand. I knew there was something wrong with this transparency of information but was not 100% sure what it was. I think I have my answer and it was enlightening.
I was first directed to the Notice to Members memo dated 9/29/2009
www.finra.org/Industry/Regulation/Notices/2009/P120045
The individual I spoke with wanted to make clear that to maintain proper trade volume reporting accuracy, a trade with multiple legs in the trade would only be reported once in the volume reports. The example given would be.
Investor A is long 100 shares and wants to sell. They enter the order through their broker that is routed to a market maker. That market maker will go out and sell the stock into the market before they have bought the stock from you/your broker to close out their account. They do not take possession first as there is no guarantee they can sell the order into the market. By this Notice, the actual sale INTO the market is a short sale because the market maker sold the stock into the market BEFORE they had purchased the stock from you. It is a technicality since they know there position will be closed out minutes later when they go in and buy your shares. To avoid doubling up on trade volume and distorting the picture, only the sale into the market (consolidated tape) is recorded and not the second leg which was the sale transaction between seller and market maker.
So, this is why the short sale volume is high but also why the FTD’s and bi-Monthly short interest reports are not showing any indications of this volume. The short isn’t really a short it is the execution of a long sale by a market maker.
Hound, all purchases below 1.90 are gravy at-this-point. Once this stock sustains 2, that will be the last-time for cheap shares... Many biotech/drug companies will be interested for deals as trial results come in. That includes all 3 drugs (KPB)... Would not be surprised to see a buyout offer for the entire company... Pipelines are drying up for the mid/large size players...
One-year chart suggests a breakout above 3 if 2.05 can hold. Positive (P results) would be that catalyst...
http://finance.yahoo.com/echarts?s=CTIX+Interactive#{%22allowChartStacking%22:true}
CTIX up in a down market!!! Insiders are buying up shares, while the shorts have headed to the hills..
Struggling? Great observation... Too much time on your hands to follow every trade... Sit back and be happy, it appears owning these shares is the real struggle...
Yes, Limping into the close? The Earth is doomed, better sell out the pain is tremendous.
Great Blzzy, keep emailing the CEO's so you can justify your investment. Usually, the OTCBB Ceo's are the only ones to respond though... All the info I need on CTIX is right in-front-of-me. Real simple math, either they succeed in their trials or not?
That's great, most shareholders don't email CEO's as they usually have enough confidence in their investment.
The daily short interest report from FINRA is as widely misinterpreted as any report ever put out. Yet, once a few basics are understood, it becomes very logical. The huge short volume seen in the daily reports are almost instantaneously covered; within a few milliseconds or a few hours at worst. The best explanation of this report, that I've ever seen, was posted by "Dave Patch" of "Investigatethesec.com."
Posted by: patchman Date: Wednesday, March 03, 2010 6:31:31 PM
In reply to: fourkids_9pets who wrote msg# 648 Post # of 951
Short Sale Volume Reporting’s are deceiving.
I spoke to FINRA today and found out some very interesting things that until now I did not fully understand. I knew there was something wrong with this transparency of information but was not 100% sure what it was. I think I have my answer and it was enlightening.
I was first directed to the Notice to Members memo dated 9/29/2009
www.finra.org/Industry/Regulation/Notices/2009/P120045
The individual I spoke with wanted to make clear that to maintain proper trade volume reporting accuracy, a trade with multiple legs in the trade would only be reported once in the volume reports. The example given would be.
Investor A is long 100 shares and wants to sell. They enter the order through their broker that is routed to a market maker. That market maker will go out and sell the stock into the market before they have bought the stock from you/your broker to close out their account. They do not take possession first as there is no guarantee they can sell the order into the market. By this Notice, the actual sale INTO the market is a short sale because the market maker sold the stock into the market BEFORE they had purchased the stock from you. It is a technicality since they know there position will be closed out minutes later when they go in and buy your shares. To avoid doubling up on trade volume and distorting the picture, only the sale into the market (consolidated tape) is recorded and not the second leg which was the sale transaction between seller and market maker.
So, this is why the short sale volume is high but also why the FTD’s and bi-Monthly short interest reports are not showing any indications of this volume. The short isn’t really a short it is the execution of a long sale by a market maker. The key language in the FINRA notice is this:
Asking the CEO, then posting his response has not worked out for the company/shareholders. in fact, it cost them an up-listing and probably other advances. Keep quiet, release news when it's factual and act like a real CEO... Why investors keep emailing Leo is a mystery?
Wrong prediction again... Can't break 1.74, however it did break 1.70 which was greater resistance. Keep shorting the shares PLEASE!!!
The addition of Dr. Farraye made Dr Jorgensen expendable. The stock took an unfair hit, so I expect a nice rebound. Also, CTIX probably saves 100K or more in salary.
Real short interest declined by 11 percent in April.
http://www.franklinindependent.com/cellceutix-corporation-otcmktsctix-sellers-covered-11-64-of-their-shorts/
The daily short interest report from FINRA is as widely misinterpreted as any report ever put out. Yet, once a few basics are understood, it becomes very logical. The huge short volume seen in the daily reports are almost instantaneously covered; within a few milliseconds or a few hours at worst. The best explanation of this report, that I've ever seen, was posted by "Dave Patch" of "Investigatethesec.com."
Posted by: patchman Date: Wednesday, March 03, 2010 6:31:31 PM
In reply to: fourkids_9pets who wrote msg# 648 Post # of 951
Short Sale Volume Reporting’s are deceiving.
I spoke to FINRA today and found out some very interesting things that until now I did not fully understand. I knew there was something wrong with this transparency of information but was not 100% sure what it was. I think I have my answer and it was enlightening.
I was first directed to the Notice to Members memo dated 9/29/2009
www.finra.org/Industry/Regulation/Notices/2009/P120045
The individual I spoke with wanted to make clear that to maintain proper trade volume reporting accuracy, a trade with multiple legs in the trade would only be reported once in the volume reports. The example given would be.
Investor A is long 100 shares and wants to sell. They enter the order through their broker that is routed to a market maker. That market maker will go out and sell the stock into the market before they have bought the stock from you/your broker to close out their account. They do not take possession first as there is no guarantee they can sell the order into the market. By this Notice, the actual sale INTO the market is a short sale because the market maker sold the stock into the market BEFORE they had purchased the stock from you. It is a technicality since they know there position will be closed out minutes later when they go in and buy your shares. To avoid doubling up on trade volume and distorting the picture, only the sale into the market (consolidated tape) is recorded and not the second leg which was the sale transaction between seller and market maker.
So, this is why the short sale volume is high but also why the FTD’s and bi-Monthly short interest reports are not showing any indications of this volume. The short isn’t really a short it is the execution of a long sale by a market maker. The key language in the FINRA notice is this:
Quote:
--------------------------------------------------------------------------------
The Daily Short Sale Volume File will provide daily access to the aggregate volume of short sales in NMS Stocks and OTC Equity Securities reported to a consolidated tape and traded over-the-counter during regular trading hours on each trading day.
Volume is concerning? For whom? Are you selling more than 100K shares? The PPS action is great of late, building a base before the rally past 2.
Dr Stephen Sonis addition reduced the need of DR J. It was an overblown response to his departure.
http://www.marketwired.com/press-release/cellceutix-corporation-welcomes-dr-stephen-t-sonis-to-its-scientific-advisory-board-otc-ctix-2104102.htm
Dr. Sonis is arguably the world's foremost expert on cancer-related oral mucositis. Of equal importance, he is no stranger to Brilacidin, having helped research its oral rinse formulation and application prior to Cellceutix's acquisition of the compound in 2013. His expertise in clinical study design and execution will be invaluable as Brilacidin-Oral Mucositis (OM) continues to be evaluated in an ongoing Phase 2 FDA trial."
Good news, let the rebound begin. DR J leaving is a loss, but it should not have driven the stock down by 7 percent. Like others have said, maybe his importance is reduced as future phases evolve...Menon is the driving force...
KarinCA, I'm not sure CTIX is properly structured to form themselves into a mid or large size biotech. I believe they'll sell the entire ship in a few years.
Sox, Thanks for the update. Losing the number 3 man does bring up some questions. Seems odd that DR J's new project would have more potential than staying on with CTIX? Even more pressure on successful P results now.
How many employees are left now 2 or 3? For a company that's led us to believe they're the next Regeneron, they should be adding staff not subtracting.
Leo crashed his own party, stock drops to new lows. Hopefully, he has better news tomorrow...
What track record does Leo have building "any" company into a mid or large size one? He couldn't even up-list when he had 6 months to do so... This is not the next Amgen folks, please wake up and smell the coffee. This is a complete sell-off or bust within 2 years.
I agree, with Leo it's quantity of press releases versus quality... Doesn't work well, yet he continues to believe his voice has meaning.
Maybe Leo should be the next to go. Find a real CEO to take this company to the next level. Someone who can distance himself from chat-boards and can properly manage the company. The goal should be a complete sell-off of the company at-this-point. There's not enough structure in place to form CTIX into a mid-size biotech company. So, lets start taking offers...
It was fun to think 2 bucks was achievable without factual news. Today's PR was more diary info...
Another decline after a PR. Almost like clockwork.... Those wanting news got it, not sure it was worth much... Going to take successful P results to move this past 2, until then it's back to normal trading.
Look at the positive, the low PPS has remained for those to accumulate. Besides Mako, the failed up-listing was biggest drag on the PPS. So much riding on the P results...
Agree, Someone appears to be manipulating the shares to the up and downside. When it's time to end the rally, a magic switch is set... Who bought at 1.92 I wonder? LOL
The pullback appears to be underway. 1.80 key resistance if it can hold...
If 1.80 holds now, I can see 2 bucks this afternoon. My guess, there's a pile of cash for the next leg up.
All action on the bid price now... Amazing how easily this can switch on-the-dime with no news. Yesterday, the trades were mostly on the ask.
Short interest decreased by 11.64 percent from a month ago. It's been a steady decline for 6 months now.
http://www.stockcaller.com/cellceutix-corporation-otcmktsctix-sellers-covered-11-64-of-their-shorts/72734/
Cellceutix Making a Comeback Article (Insider Financial). Not sure if this was posted yet?
http://www.insiderfinancial.com/cellceutix-corp-otcmktsctix-making-a-comeback/114884/